NCT06974110 2026-01-16Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsMOMA TherapeuticsPhase 1 Recruiting132 enrolled
NCT06624644 2025-09-10A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory MelanomaLinnaeus Therapeutics, Inc.Phase 2/3 Recruiting135 enrolled
NCT04638751 2024-04-05ARGONAUT: Stool and Blood Sample Bank for Cancer PatientsPersephone BiosciencesRecruiting5,000 enrolled